Barclays PLC Liquidia Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Liquidia Corp stock. As of the latest transaction made, Barclays PLC holds 99,984 shares of LQDA stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,984

Previous 99,984 -0.0%

Holding current value

$1.43 Million

Previous $999,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$8.9 - $14.11 $646,059 - $1.02 Million	72,591 Added 265.0%	99,984 $999,000
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $738,302 - $969,794	-61,731 Reduced 69.26%	27,393 $328,000
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $157,730 - $232,496	-13,897 Reduced 13.49%	89,124 $1.31 Million
Q4 2023 Feb 15, 2024	BUY	$5.77 - $12.19 $545,109 - $1.15 Million	94,473 Added 1105.21%	103,021 $1.24 Million
Q3 2023 Nov 07, 2023	SELL	$6.27 - $8.15 $6,796 - $8,834	-1,084 Reduced 11.25%	8,548 $55,000
Q2 2023 Aug 03, 2023	SELL	$6.63 - $9.9 $96,718 - $144,421	-14,588 Reduced 60.23%	9,632 $76,000
Q1 2023 May 04, 2023	BUY	$5.72 - $7.91 $64,750 - $89,541	11,320 Added 87.75%	24,220 $168,000
Q4 2022 Feb 13, 2023	BUY	$4.68 - $6.54 $50,501 - $70,573	10,791 Added 511.66%	12,900 $82,000
Q3 2022 Nov 03, 2022	SELL	$3.73 - $8.39 $1,063 - $2,391	-285 Reduced 11.9%	2,109 $11,000
Q2 2022 Aug 12, 2022	BUY	$3.37 - $7.55 $8,067 - $18,074	2,394 New	2,394 $10,000
Q4 2021 Feb 14, 2022	SELL	$2.71 - $5.17 $10,230 - $19,516	-3,775 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.28 - $2.95 $7,225 - $9,348	-3,169 Reduced 45.64%	3,775 $10,000
Q2 2021 Aug 13, 2021	SELL	$2.51 - $3.11 $39,417 - $48,839	-15,704 Reduced 69.34%	6,944 $20,000
Q1 2021 May 13, 2021	BUY	$2.42 - $3.6 $33,645 - $50,050	13,903 Added 158.98%	22,648 $61,000
Q4 2020 Feb 11, 2021	SELL	$2.6 - $5.79 $10,431 - $23,229	-4,012 Reduced 31.45%	8,745 $26,000
Q3 2020 Nov 12, 2020	BUY	$4.34 - $8.28 $6,744 - $12,867	1,554 Added 13.87%	12,757 $63,000
Q2 2020 Aug 12, 2020	BUY	$4.86 - $11.44 $32,819 - $77,254	6,753 Added 151.75%	11,203 $95,000
Q1 2020 May 13, 2020	SELL	$3.31 - $7.15 $29,710 - $64,178	-8,976 Reduced 66.86%	4,450 $21,000
Q4 2019 Feb 10, 2020	BUY	$3.07 - $5.11 $20,151 - $33,542	6,564 Added 95.66%	13,426 $57,000
Q3 2019 Nov 14, 2019	SELL	$3.29 - $8.24 $5,898 - $14,774	-1,793 Reduced 20.72%	6,862 $25,000
Q2 2019 Aug 14, 2019	BUY	$7.92 - $11.39 $21,360 - $30,718	2,697 Added 45.27%	8,655 $69,000
Q1 2019 May 15, 2019	BUY	$10.82 - $21.79 $64,465 - $129,824	5,958 New	5,958 $68,000
Q4 2018 Feb 14, 2019	SELL	$16.38 - $37.18 $29,926 - $67,927	-1,827 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.96 - $28.9 $20,023 - $52,800	1,827 New	1,827 $50,000

Others Institutions Holding LQDA

# of Institutions

170

Shares Held

44.3M

Call Options Held

1.55M

Put Options Held

1.52M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $918M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account